1 Heberden W. Medical transactions published by the College of Physicians in London. Londres, Barker S, Doodley J 1772.
2 Brunton TL. On the use of nitrite of amyl in angina pectoris. The Lancet 1867;90(2291):97–8.
3 Murrell W. Nitroglycerin as a remedy for angina pectoris. Lancet. 1879;113:113–115.
4 Black J. Nobel lecture in physiology or medicine 1988. Drugs from emasculated hormones: the principle of syntopic antagonism. In vitro cellular & developmental biology: journal of the Tissue Culture Association 1989;25(4):311–20.
5 Favaloro RG. 50th anniversary historical article. Surgical treatment of acute myocardial infarction. Journal of the American College of Cardiology. 1999;33(6):1435-41.
6 Meier B, Bachmann D, Luscher T. 25 years of coronary angioplasty: almost a fairy tale. Lancet (London, England). 2003;361(9356):527.
7 Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet (London, England). 2017.
8 G K. ‘Unbelievable’: Heart stents fail to ease chest pain. New York Times 2017.
9 G K. ‘Unbelievable’: Heart stents fail to ease chest pain. New York Times 2017.
10 Brown DL, Redberg RF. Last nail in the coffin for PCI in stable angina? Lancet (London, England). 2017.
11 Chaitman BR. Exaggerated exercise-induced sytolic blood pressure response: arterial baroreceptor sensitivity or carotid stiffness? European heart journal. 2017.
12 Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. European heart journal. 2005;26(23):2529–36.
13 Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002;105(11):1291–7.
14 Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Jama. 2004;291(3):309–16.
15 Chaitman BR, Skettino SL, Parker JO, Hanley P, Meluzin J, Kuch J, et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. Journal of the American College of Cardiology. 2004;43(8):1375–82.
16 Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, et al. Effect of PCI on quality of life in patients with stable coronary disease. The New England journal of medicine. 2008;359(7):677–87.
17 Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ. 2014;348:g3859.
18 Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European heart journal. 2013;34(38):2949–3003.
19 Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European heart journal. 2014;35(37):2541–619.
20 Investigators IT. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA). Identifier NCT01471522. 2013.